Answers are grounded in this paper and cite their sources.
The medical, payer-perspective, direct cost of non-optimized prescription medication use in the United States was recently measured in excess of 528 USD billion. This value incorporated the downstr...
No takes yet. Share an insight, caveat, or question.
Jonathan Hirohiko Watanabe (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: